What is the key to healthy aging? New gene study sheds light

Source: What is the key to healthy aging? New gene study sheds light – Medical News Today

A new study may bring us closer to unlocking the secret to healthy aging, after uncovering an array of genetic variants among healthy, elderly individuals that may protect against Alzheimer’s and heart disease.
[Happy older people in a circle]
Researchers have uncovered some of the secrets of healthy aging with their new gene study.

The findings come from the ongoing “Wellderly” study, in which researchers have so far applied whole genome sequencing to the DNA of more than 1,400 healthy individuals from the US aged 80-105 years.

Launched in 2007, the study aims to pinpoint certain genetic variants that may contribute to lifelong health.

“This study is exciting because it is the first large one using genetic sequencing to focus on health,” says Michael Snyder, PhD, chairman of the Department of Genetics at Stanford University in California, who was not involved with the research.

“Most of the world’s scientists are studying disease, but what we really want to understand is what keeps us healthy. That is what the Wellderly study is all about.”

Lower genetic risks for Alzheimer’s, heart disease for the Wellderly

To reach the new findings – published in the journal Cell – co-senior study author Dr. Eric Topol, director of the Scripps Translational Science Institute (STSI) in La Jolla, CA, and colleagues used the Complete Genomics sequencing platform to analyze the genomes of 600 Wellderly participants.

Fast facts about the aging population

  • Worldwide, the number of people aged 60 and older will rise to 2 billion by 2050
  • By 2020, people aged 60 and older will outnumber children younger than 5 years for the first time
  • In 2050, 80% of older adults will be living in low- and middle-income countries.

Learn more about aging

All subjects were free of cancer, stroke, Alzheimer’s disease, Parkinson’s disease, diabetes, heart attack and any other chronic disease or illness.

Their genomes were compared with those of 1,507 adults who represented the general population and who were part of a study conducted by the Inova Translational Medicine Institute (ITMI) in Falls Church, VA.

After controlling for blood relatedness and ethnic differences among the participants, the researchers were left with 511 individuals from the Wellderly study and 686 people from the ITMI cohort for whom they conducted downstream DNA analyses.

All in all, the researchers analyzed 24,205,551 specific gene variants across both groups.

Compared with the ITMI cohort, participants from the Wellderly study had lower genetic risks for Alzheimer’s disease and coronary artery disease – the most common form of heart disease.

However, the team identified no difference in genetic risks for cancer, stroke or type 2 diabetes between the two groups, suggesting that participants of the Wellderly study possess other genetic characteristics or protective behaviors that prevent them from developing these diseases.

“We didn’t find a silver bullet for healthy longevity,” notes study co-author Ali Torkamani, PhD, director of genome informatics at STSI. “Instead, we found weaker signals among common as well as rare variant sites, which collectively suggest that protection against cognitive decline contributes to healthy aging.”

COL25A1 gene variant discovery may lead to new Alzheimer’s treatments

Interestingly, the researchers identified a number of very rare variants in the COL25A1 gene of 10 individuals who were part of the Wellderly study. Such variants were not found in the ITMI cohort.

The team explains that COL25A1 encodes for a key component of amyloid plaques, which are clumps of beta-amyloid protein that are found in the brains of people with Alzheimer’s.

“Those gene variants might offer a pathway for the development of new treatments for Alzheimer’s,” notes Torkamani.

The Wellderly study is set to continue and, based on the findings to date, the researchers are confident that the study will offer much-needed insight into the genetics behind healthy aging.

Commenting on the research, Eric Schadt, PhD, director of the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai in New York, NY, says:

“For many decades, we have searched for the genetic causes of disease in sick individuals. The Wellderly study presents an attractive alternative by studying those who are well in order to uncover the solutions nature has provided to protect us against disease.

The initial discoveries around protective factors for Alzheimer’s disease and coronary artery disease demonstrate the keys the Wellderly may hold in unlocking ways in which we all may live healthier lives.”

Last month, Medical News Todayinvestigated whether the effects of aging can be reversed.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s